Hormonal
Weight loss achieved through GLP-1 agonists or lifestyle interventions improves the severity and treatment response of immune-mediated skin diseases like psoriasis and hidradenitis suppurativa.
If you have psoriasis or hidradenitis suppurativa, losing weight can directly reduce the severity of your skin lesions and improve how well your treatments work. This is because excess fat tissue drives inflammation. Managing your weight helps calm the underlying immune response.
La pérdida de peso se asocia con una disminución de la gravedad de la PsO y mejor calidad de vida... La pérdida de peso en pacientes con HS conduce a una disminución relevante del número de lesiones y, en algunos casos, a la remisión de la enfermedad.
Why this rating
Based on observational associations and small case series for GLP-1s in skin disease, but stronger evidence exists for general weight loss benefits.
Source
Agonistas del receptor de GLP-1 para el tratamiento de la obesidad en pacientes con dermatosis inmunomediadas
Eva Vilarrasa et al. · Actas Dermo-Sifiliográficas · 2023
DOI 10.1016/j.ad.2023.06.017
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →